Literature DB >> 7962876

Toward the incorporation of costs, cost-effectiveness analysis, and cost-benefit analysis into clinical research.

B T Yates1.   

Abstract

Most research in clinical psychology and related disciplines does not measure, report, or analyze costs, cost-effectiveness, or cost-benefit analysis. Reasons for this are discussed. It may be thought, for example, that costs are trivial to measure. Data are presented to show that the values of resources consumed in treatment (i.e., costs) actually can be quite complex to assess accurately and completely. Research findings are assembled to show that costs, as experienced by clients, may be beneficial to assess in that they can be significantly related to the outcomes of treatment. Empirical findings also show that costs also can be useful to measure because costs and outcomes can be related inversely rather than directly (i.e., clients may benefit most from treatments that cost less than several viable alternatives). Finally, perceived impediments to assessing costs and to cost-effectiveness and cost-benefit analysis in psychology are considered. Dialogue is encouraged on the scientific study of relationships between (a) monetary and other costs, (b) treatment techniques and treatment delivery systems, and (c) psychological and economic outcomes.

Mesh:

Year:  1994        PMID: 7962876     DOI: 10.1037//0022-006x.62.4.729

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  13 in total

Review 1.  Family-based therapy for adolescent drug abuse: knowns and unknowns.

Authors:  T J Ozechowski; H A Liddle
Journal:  Clin Child Fam Psychol Rev       Date:  2000-12

2.  Methadone programmes. The costs and benefits to society and the individual.

Authors:  G E Ralston; P Wilson
Journal:  Pharmacoeconomics       Date:  1996-10       Impact factor: 4.981

3.  An evaluation of the effectiveness of recruitment methods: the staying well after depression randomized controlled trial.

Authors:  Adele Krusche; Isabelle Rudolf von Rohr; Kate Muse; Danielle Duggan; Catherine Crane; J Mark G Williams
Journal:  Clin Trials       Date:  2014-04       Impact factor: 2.486

Review 4.  A vision of the next generation of behavioral therapies research in the addictions.

Authors:  Kathleen M Carroll; Bruce J Rounsaville
Journal:  Addiction       Date:  2007-06       Impact factor: 6.526

5.  Influences on practitioner treatment selection: best research evidence and other considerations.

Authors:  Timothy D Nelson; Ric G Steele
Journal:  J Behav Health Serv Res       Date:  2007-10-03       Impact factor: 1.505

6.  Comparison of a family-based group intervention for youths with obesity to a brief individual family intervention: a practical clinical trial of positively fit.

Authors:  Ric G Steele; Brandon S Aylward; Chad D Jensen; Christopher C Cushing; Ann M Davis; James A Bovaird
Journal:  J Pediatr Psychol       Date:  2011-08-18

7.  Patient and program costs, and outcomes, of including gender-sensitive services in intensive inpatient programs for substance use.

Authors:  Sarah E Hornack; Brian T Yates
Journal:  Eval Program Plann       Date:  2017-09-01

8.  Predictors of engagement in a parenting intervention designed to prevent child maltreatment.

Authors:  Phadedra S Corso; Xiangming Fang; Angela M Begle; Jean Dumas
Journal:  West J Emerg Med       Date:  2010-08

9.  Perspective from an NGO.

Authors:  R Thara
Journal:  Indian J Psychiatry       Date:  2005-10       Impact factor: 1.759

10.  Research priorities for economic analyses of prevention: current issues and future directions.

Authors:  D Max Crowley; Laura Griner Hill; Margaret R Kuklinski; Damon E Jones
Journal:  Prev Sci       Date:  2014-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.